Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma-Reference-Cited by-同舟云学术

Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma

Published:2017-09-27 Issue:3 Volume:110 Page:290-303
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Audrito Valentina¹²,Managò Antonella¹²,La Vecchia Sofia¹²,Zamporlini Federica³,Vitale Nicoletta⁴,Baroni Gianna⁵,Cignetto Simona¹²,Serra Sara¹²,Bologna Cinzia¹²,Stingi Aureliano¹²,Arruga Francesca¹²,Vaisitti Tiziana¹²,Massi Daniela⁵,Mandalà Mario⁶,Raffaelli Nadia³,Deaglio Silvia¹²

Affiliation:

1. Department of Medical Sciences, University of Turin, Italy

2. Italian Institute for Genomic Medicine, Turin, Italy

3. Department of Agricultural, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy

4. Department of Molecular Biotechnologies and Health Science, University of Turin, Italy

5. Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Italy

6. Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/110/3/290/24280932/djx198.pdf

Reference41 articles.

1. Regulation of cancer cell metabolism;Cairns;Nat Rev Cancer,2011

2. The NAD metabolome—a key determinant of cancer cell biology;Chiarugi;Nat Rev Cancer.,2012

3. NAD(+) in aging, metabolism, and neurodegeneration;Verdin;Science.,2015

4. NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism;Burgos;Curr Med Chem.,2011

5. Physiological and pathophysiological roles of NAMPT and NAD metabolism;Garten;Nat Rev Endocrinol,2015

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review;Expert Opinion on Therapeutic Patents;2024-06-13

2. RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition;Molecular Cancer;2024-05-16

3. Targeting NAD+ metabolism: dual roles in cancer treatment;Frontiers in Immunology;2023-12-05

4. Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian Cancer;Cancers;2023-08-18

5. BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers;Cancers;2023-08-08